Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 3/2010

01.06.2010 | Short Research Report

Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity

verfasst von: Geoffrey C. Wall, Jane E. DeWitt, Sally Haack, Anisa Fornoff, Darla K. Eastman, Carrie F. Koenigsfeld

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective Pharmacists are commonly confronted with patients with a history of sulfonamide allergy. Basic immunologic and clinical data suggest a low likelihood of a patient with a history of sulfonamide hypersensitivity developing an allergic reaction to a non-antimicrobial sulfonamide drug. We conducted a survey to describe the knowledge and attitudes of licensed pharmacists concerning sulfonamide allergy cross-reactivity. Methods A survey instrument was developed and sent to all licensed pharmacists in the state of Iowa. The survey recorded demographic information and included six patient scenarios designed to elicit responses concerning sulfonamide allergy cross-reactivity with a number of non-antimicrobial sulfonamides. Results A total of 421 surveys were returned for a 39% response rate. There was a wide discrepancy in approaches to patients with a history of sulfonamide allergy prescribed a sulfonamide containing non-antibiotic. Differences depended on previous history of tolerating the medication in question, the degree of cautionary statements in product literature, and the familiarity the pharmacist had with the product. Conclusion Our survey suggests a significant diversity in knowledge and attitudes of pharmacists concerning cross-reactivity of sulfonamide antimicrobials and other drugs with a sulfonamide moiety. Depth of training in this area may be an associative factor.
Literatur
2.
Zurück zum Zitat Demoly P, Gomes ER. Drug hypersensitivities: definition, epidemiology and risk factors. Eur Ann Allergy Clin Immunol. 2005;37:202–6.PubMed Demoly P, Gomes ER. Drug hypersensitivities: definition, epidemiology and risk factors. Eur Ann Allergy Clin Immunol. 2005;37:202–6.PubMed
3.
Zurück zum Zitat Farrell J, Naisbitt DJ, Drummond NS, et al. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther. 2003;306:229–37.CrossRefPubMed Farrell J, Naisbitt DJ, Drummond NS, et al. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther. 2003;306:229–37.CrossRefPubMed
4.
Zurück zum Zitat Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565–71.CrossRefPubMed Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565–71.CrossRefPubMed
5.
Zurück zum Zitat Patterson R, Bellow AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther. 1999;21:2065–79.CrossRefPubMed Patterson R, Bellow AE, Lefkowith J. Immunologic tolerability profile of celecoxib. Clin Ther. 1999;21:2065–79.CrossRefPubMed
6.
Zurück zum Zitat Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antimicrobials and sulfonamide nonantimicrobials. N Engl J Med. 2003;349:1628–35.CrossRefPubMed Strom BL, Schinnar R, Apter AJ, et al. Absence of cross-reactivity between sulfonamide antimicrobials and sulfonamide nonantimicrobials. N Engl J Med. 2003;349:1628–35.CrossRefPubMed
Metadaten
Titel
Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity
verfasst von
Geoffrey C. Wall
Jane E. DeWitt
Sally Haack
Anisa Fornoff
Darla K. Eastman
Carrie F. Koenigsfeld
Publikationsdatum
01.06.2010
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 3/2010
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9389-6

Weitere Artikel der Ausgabe 3/2010

International Journal of Clinical Pharmacy 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.